Copyright
©The Author(s) 2025.
World J Clin Oncol. May 24, 2025; 16(5): 103830
Published online May 24, 2025. doi: 10.5306/wjco.v16.i5.103830
Published online May 24, 2025. doi: 10.5306/wjco.v16.i5.103830
Figure 3 Relative mRNA expression of homeobox C6 in bladder cancer cell lines.
A: Relative mRNA expression of homeobox C6 (HOXC6) in EJ-1, 5637, J82, and HT-1376 (compared to the EJ-1 group); B: Relative expression of HOXC6 after transfection with siRNA (compared to 5637 + control group). cP < 0.005; dP < 0.001; CK: Control group; NC: Negative control group; HOXC6: Homeobox C6.
- Citation: Lu DJ, Wang HR, Xu YS, Huang HB, Zhong QG, Luo YN, Qi JF, Wu HC, Pei JY, Zhang K, Xu CX, Wang TX, Zhang W, Zhou YH, Huang ZG, Wang FB. Homeobox C6 plays an oncogenic role in bladder cancer. World J Clin Oncol 2025; 16(5): 103830
- URL: https://www.wjgnet.com/2218-4333/full/v16/i5/103830.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i5.103830